| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |